Search
Nalezeno "biotech": 2
Bitcoin’s 60% year-to-date correction looks bad, but many stocks have dropped by even more
22.9.2022
Legacy investors often say BTC, ETH and altcoin volatility is too high to warrant a sound investment, but many major corporations have seen even larger drawdowns in their stock prices in 2022
Analyst Expects Bitcoin to ‘Grind Down’ to $15K, With a ‘Periodic Dead Cat Bounce’ Along the Way
26.5.2021
An analyst from the biotech consulting group Biotechvalley Insights believes after bitcoin lost 53% from the crypto asset’s all-time high, “the party is clearly over.” The biotech consulting group analyst thinks crypto investors will witness a slow “grind down the slope...